Penn State researchers deliver melanoma drug combo using nanoparticles

Researchers from the Penn State College of Medicine developed a method to deliver a combination of drugs using nanoparticles in the hopes of preventing melanoma cancer cells from developing treatment-resistance. Their work was published in Molecular Cancer Therapeutics and Cancer Letters. 

The team’s CelePlum-777 localized around cancer tumors and delivered a specific ratio of an anti-inflammatory, Celecoxib, and a toxin, Plumbagin, the researchers reported.

Get the full story at our sister site, Drug Delivery Business News.

The post Penn State researchers deliver melanoma drug combo using nanoparticles appeared first on MassDevice.

from MassDevice http://ift.tt/2m4Z6q0